Anti-D immunoglobulin dosage in pregnancy

The correct anti-D immunoglobulin dose depends on the product, pregnancy stage, clinical event, and the maternity team's protocol. It should be prescribed and administered by a qualified clinician rather than calculated at home. In some situations, testing for fetal red blood cells in the pregnant person's circulation helps the team decide whether more anti-D is required.

Anti-D immunoglobulin is offered to eligible RhD-negative pregnant people who have not already formed immune anti-D antibodies. It reduces the chance that their immune system will react to RhD-positive fetal red blood cells that enter their circulation. The dose on one person's record may therefore differ from another person's prescription.

Clinicians consider whether anti-D is being given routinely, after birth, or after a potentially sensitising event such as vaginal bleeding, abdominal injury, pregnancy loss, or an invasive obstetric procedure. Brand formulations and local maternity protocols can also differ, so dose units should be read directly from the prescription and product label.

Tell the maternity team your blood group if known, whether you have received anti-D during this pregnancy, and when any bleeding, injury, procedure, or pregnancy complication occurred. Bring your maternity record or injection documentation. The team can confirm your eligibility, the product, the prescribed dose, and whether a blood test or additional dose is needed.

If you missed an appointment or are unsure whether the full injection was given, contact the maternity service promptly. Do not use a dose found online or repeat an injection without clinical direction. After administration, make sure the date, product, dose, and batch details are recorded for continuity of care.

Contact your maternity assessment service promptly after vaginal bleeding, abdominal trauma, a procedure involving the pregnancy, or if you were told you may need anti-D but did not receive it. Seek urgent assessment for heavy bleeding, severe abdominal pain, fainting, breathing difficulty, facial or throat swelling, or rapidly worsening symptoms after an injection. These symptoms need assessment regardless of whether anti-D is due.

Ask why anti-D is recommended in your situation, which product and dose are prescribed, and whether testing could change the amount required. Also confirm when the injection should be given, which reactions to watch for, whether follow-up is needed, and where the administration details will be recorded.